Get started
Author

Marc Müller

Observed names: M. MULLER, M. Muller, Marc Muller, Muller, Marc
ORCID: 0000-0002-7190-7684
Observed ORCID: 0000-0002-7190-7684
OpenAlex ID: A5061049570
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
2017 · Olivier Bluteau, Marie Sebert, et al. · Blood · 371
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012 · M. Baccarani, S. Pileri, et al. · Annals of Oncology · 112
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
2019 · Elise Chapiro, Elodie Pramil, et al. · Blood · 53
PDF
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial
2021 · Francois Guilhot, Françoise Rigal-Huguet, et al. · Leukemia · 30
Serum albumin or body mass index: Which prognostic factor for survival in patients with acute myeloblastic leukaemia?
2018 · Lauriane Filliatre‐Clement, Julien Broseus, et al. · Hematological Oncology · 29
Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors
2007 · Xiaohong Lu, Jean-Noël Freund, et al. · Biochimie · 24
Interference of blast cell fragments with automated platelet counting
2015 · B. Frotscher, S. Salignac, et al. · International Journal of Laboratory Hematology · 14
NAP 1L1‐ MLLT 10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T‐cell acute lymphoblastic leukaemia
2015 · Jonathan Bond, Aurore Touzart, et al. · British Journal of Haematology · 7
PDF
Allogeneic stem cell transplantation-A curative treatment for paroxysmal nocturnal hemoglobinuria with PIGT mutation: A case report
2022 · Laurence Schenone, Anne-Béatrice Notarantonio, et al. · World Journal of Clinical Cases · 6
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots
2023 · Grégory Lazarian, Bernard Leroy, et al. · Human Mutation · 4
PDF
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
2022 · Grégory Lazarian, Floriane Theves, et al. · American Journal of Hematology · 4
PDF
Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group
2018 · Elise Chapiro, Damien Roos-Weil, et al. · Blood · 4
Cryoglobulin detection from blood and peritoneal fluid smears
2010 · J.-F. LESESVE, M. MULLER, et al. · International Journal of Laboratory Hematology · 4
Thermally induced popcorn red blood cells
2009 · Marc Muller, Sylvain Salignac, et al. · Transfusion · 4
Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report
2018 · M. D’Aveni-Piney, M. Divoux, et al. · Journal of Medical Case Reports · 2
PDF
The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique
2024 · Florence Nguyen‐Khac, Marc Muller, et al. · American Journal of Hematology · 1
PDF
The t(X;5)(q13;q33) Translocation in Myeloid Neoplasms Is Preferentially Associated With Chronic Myelomonocytic Leukemia: A Report From the Groupe Francophone de Cytogénétique Hématologique
2026 · Florence Nguyen‐Khac, Marc Muller, et al. · Genes Chromosomes and Cancer
Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of IDH Variants in Solid Tumors and Hematological Malignancies
2026 · Pauline Gilson, Marc Muller, et al. · International Journal of Molecular Sciences
PDF
Enhanced Heterologous Immuno-Boost (EHIB) Covid-19 Vaccines: a NOVEL CONCEPT: Enhanced Heterologous Immuno-Boost Covid-19 Vaccines
2023 · Abbas, Shahid, Selamoğlu, Zeliha, et al. · Eurasian Journal of Medical and Biological Sciences
Investigation of large granular lymphocytic leukemias: data from the laboratory of hematology at Nancy University Hospital, France
2022 · Charles Guisnel, Jean-François Lesesve, et al. · Annales de biologie clinique
PDF
Pb1868 B‐cell Prolymphocytic Leukemia (b‐pll) and Prolymphocytoid Mantle Cell Lymphoma (pmcl) (more Than 55% of Prolymphocytes) Are Closed but Distinct Entities. on Behalf Gfch and Filo Groups
2019 · E. Chapiro, K. Diop, et al. · HemaSphere
Diversity of TP53 Mutations in CLL: Retrospective Analysis of 450 Mutations from the French Innovative Leukemia Organization (FILO) Group
2017 · Myriam Hormi, Fanny Baran-Marszak, et al. · Clinical Lymphoma Myeloma & Leukemia
2.14 The Kinetics of Phosphorylation of the CD5 Regulatory Domain in Chronic Lymphocytic Leukemia B Cells Reflects Ongoing Activation of the B-Cell Receptor
2011 · Hélène Gary-Gouy, Marc Muller, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 23
Citation count: 669
H-index: 7
I10-index: 7
Year
Topic
Type